Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
A P Fontenot, M Torres, W H Marshall, L S Newman, B L Kotzin
Index: Proc. Natl. Acad. Sci. U. S. A. 97(23) , 12717-22, (2000)
Full Text: HTML
Abstract
Chronic beryllium disease results from beryllium exposure in the workplace and is characterized by CD4(+) T cell-mediated inflammation in the lung. Susceptibility to this disease is associated with particular HLA-DP alleles. We isolated beryllium-specific T cell lines from the lungs of affected patients. These CD4(+) T cell lines specifically responded to beryllium in culture in the presence of antigen-presenting cells that expressed class II MHC molecules HLA-DR, -DQ, and -DP. The response to beryllium was nearly completely and selectively blocked by mAb to HLA-DP. Additional studies showed that only certain HLA-DP alleles allowed presentation of beryllium. Overall, the DP alleles that presented beryllium to disease-specific T cell lines match those implicated in disease susceptibility, providing a mechanism for this association. Based on amino acid residues shared by these restricting and susceptibility DP alleles, our results provide insight into the residues of the DP beta-chain required for beryllium presentation.
Related Compounds
Related Articles:
[Diagnosis of chronic berylliosis].
1999-04-01
[Pneumologie 53(4) , 193-8, (1999)]
1997-12-01
[Am. J. Respir. Crit. Care Med. 156(6) , 1884-91, (1997)]
Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
2002-11-01
[J. Clin. Invest. 110(10) , 1473-82, (2002)]
2011-02-01
[Toxicol. Sci. 119(2) , 257-69, (2011)]
Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
2009-01-01
[J. Appl. Toxicol. 29(1) , 27-35, (2009)]